CAZZANIGA MARINA ELENA

Ilari, A., Cogliati, V., Sherif, N., Grassilli, E., Ramazzotti, D., Cordani, N., et al. (2024). Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer. BIOMEDICINES, 12(2) [10.3390/biomedicines12020272]. Dettaglio

Cordani, N., Mologni, L., Piazza, R., Cogliati, V., Pepe, F., Capici, S., et al. (2023). Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells. In Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX (pp.13-21). AACR [10.1158/1538-7445.SABCS22-P1-13-21]. Dettaglio

Cordani, N., Bianchi, T., Ammoni, L., Cortinovis, D., Cazzaniga, M., Lissoni, A., et al. (2023). An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(15) [10.3390/ijms241511890]. Dettaglio

Aurisicchio, L., Brambilla, N., Cazzaniga, M., Bonfanti, P., Milleri, S., Ascierto, P., et al. (2023). A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19. MOLECULAR THERAPY, 31(3 (1 March 2023)), 788-800 [10.1016/j.ymthe.2022.12.017]. Dettaglio

Cordani, N., Lisini, D., Coccè, V., Paglia, G., Meanti, R., Cerrito, M., et al. (2023). Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC). INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(6), 1-16 [10.3390/ijms24065864]. Dettaglio